AFP and hepatocellular carcinoma: Moreover, the decision not to analyze a cohort of patients undergoing a single specific HCC treatment could be considered a limit of the study; however, this decision was driven by the purpose of assessing the predictive role of different AFP cut-offs in a wider, real-world-setting cohort, irrespective of the curative treatment performed.